One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...

WASHINGTON (Reuters) - U.S. patients who use certain asthma inhalers made with ozone-depleting propellants should talk to their doctors now about alternatives ahead of a ban that starts in January, ...

Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

"I've had asthma for years and was getting along very well with the assistance of a CFC inhaler. One day I went to the drug store to pick up a new prescription for a CFC inhaler and noticed it said ...